Cell Cure Neurosciences Ltd. Sustainability Profile
Cell Cure Neurosciences Ltd., a pioneering biotechnology company based in Israel, focuses on developing innovative cell-based therapies for neurodegenerative diseases. Founded in 2001, the company has made significant strides in the field of regenerative medicine, particularly in the treatment of conditions such as retinal diseases and Parkinson's disease. With a strong emphasis on research and development, Cell Cure Neurosciences is renowned for its unique approach to harnessing stem cell technology. Their flagship product, a cell-based therapy for retinal degenerative diseases, showcases the potential of their cutting-edge methodologies. The company has established a solid market position, recognised for its commitment to advancing neurotherapeutics and improving patient outcomes. Through strategic partnerships and collaborations, Cell Cure continues to lead the way in the biotechnology industry, driving innovation and hope for those affected by debilitating neurological conditions.
DitchCarbon Score
How does Cell Cure Neurosciences Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cell Cure Neurosciences Ltd.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cell Cure Neurosciences Ltd.'s reported carbon emissions
Cell Cure Neurosciences Ltd., headquartered in Israel (IL), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Cell Cure Neurosciences Ltd. may inherit climate-related data and commitments from its parent organization; however, no specific details or figures have been provided regarding such cascaded information. The company appears to be in the early stages of establishing its climate commitments and emissions reporting framework. In the context of the biotechnology industry, it is increasingly important for companies to adopt robust sustainability practices and set measurable targets to mitigate their environmental impact. As of now, Cell Cure Neurosciences Ltd. has not publicly outlined any specific initiatives or commitments in this regard.
How Carbon Intensive is Cell Cure Neurosciences Ltd.'s Industry?
How Carbon Intensive is Cell Cure Neurosciences Ltd.'s Location?
Cell Cure Neurosciences Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cell Cure Neurosciences Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
